Bank Of New York Mellon Corp Opgen Inc Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $62.0 $3,389 - $1.75 Million	28,242 New	28,242 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.79 $26 - $65	-83 Reduced 0.2%	40,476 $22,000
Q3 2021 Nov 12, 2021	BUY	$2.18 - $3.58 $61,567 - $101,106	28,242 Added 229.29%	40,559 $117,000
Q2 2021 Aug 11, 2021	SELL	$1.95 - $2.8 $4,379 - $6,288	-2,246 Reduced 15.42%	12,317 $27,000
Q1 2021 May 13, 2021	SELL	$1.8 - $3.55 $1,891 - $3,731	-1,051 Reduced 6.73%	14,563 $36,000
Q2 2020 Aug 12, 2020	SELL	$1.88 - $2.59 $1 - $2	-1 Reduced 0.01%	15,614 $31,000
Q1 2020 May 06, 2020	BUY	$1.14 - $4.04 $17,801 - $63,084	15,615 New	15,615 $39,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.